Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
Key takeaways
- Over 15 years, AMGN outperformed the market, turning a $1,000 investment into over $8,000 thanks to strong compounded returns.
- 14.92% annualized return
- 1.91% market outperformance
- $241.16 billion market cap
What happened
Amgen (NASDAQ: AMGN) has delivered an average annual return of 14.92% over the past 15 years, outperforming the market by 1.91% on an annualized basis.
Why it matters
The figure shows how a long‑term investment in AMGN could have generated significant wealth, illustrating the power of compound growth and the company’s strong performance relative to the broader market.
Short-term and longer-term
Short-term. For short‑term traders, AMGN’s long‑term track record may signal resilience, but the stock’s recent volatility and sector rotation risks mean it should be watched for earnings surprises and biotech regulatory news.
Longer-term. Long‑term investors can view AMGN as a solid growth play, given its 14.92% annualized return and sizable market cap.